Phoqus joins forces with GSK on oral drug delivery system, Qtrol
Phoqus pharmaceuticals reaches milestone in GSK deal on Qtrol, due to an increasing demand for drug delivery system.
Phoqus pharmaceuticals reaches milestone in GSK deal on Qtrol, due to an increasing demand for drug delivery system.
Baxter is expanding its lyophilisation capacity at its German facility to support future growth of its contract manufacturing business for anti-cancer drugs.
Indian pharma firm Panacea Biotec has taken a 10 percent stake in UK-based vaccine maker Cambridge Biostability (CBL) for £1.9m (€1.4m) under a new joint venture deal signed between the two companies.
US biotechnology company Genzyme invests heavily in Lyon, boosting their biotech-production operations in Europe
Packaging maker Alcan has announced it will invest $27.5m (€20.7m) for an expansion project in its US pharma centre to meet the growing demand for pharmaceutical flexible packaging materials.
Galapagos is to spend up to €19.1m to acquire Inpharmatica in order to accelerate their drug discovery capabilities, especially in the early stages of development.